Chengdu Shengnuo Biopharm Co., Ltd

Chengdu kaijie biological and pharmaceutical science and technology development co., LTD. Is a specialized high-tech enterprise engaged in the production and research of polypeptide drugs. Its main industries are the production of polypeptide raw drugs, the synthesis of polypeptide samples for scientific research and the development of industrial production process of polypeptide drugs. Since its establishment in 2003, the company has developed into a world-class pharmaceutical manufacturing and r&d enterprise with a total area of more than 12 hectares, and its customers are mainly from large contracted pharmaceutical factories in North America and Europe, covering more than 1,300 enterprises and r&d institutions in 69 countries around the world. Another subsidiary of its group company, chengdu shengnuo bio-pharmaceutical co., LTD., has two GMP certificates and one preparation production certification. Among the nearly 100 other products, 41 have been submitted for review. The company is the industry since the establishment of the fastest sFDA review of raw drug manufacturers. The annual production capacity of thymic pentapeptides and somatostatin is up to 30 kg. Freeze-dried powder injection was certified by GMP in September 2009, with an annual production capacity of over 10 million bottles. Chengdu capgemini professional advantage: chemical experts for decades engaged in peptide drug development company at the core of leadership, to all branches of professional scientific research philosophy throughout the enterprise and every employee, chengdu capgemini biological medicine science and technology development co., LTD. Is committed to be the Asian research strongest, the most scale of production of the API. In early 2007, the board of directors of the company recruited a doctor of production management from a large pharmaceutical enterprise in California and a chemist from the department of biology, Cambridge university in the United Kingdom. The optimized management system and production process pushed chengdu kaijie to a new height. The most in China: the polypeptide pharmaceutical industry has the largest production scale, the highest annual output value and the largest number of r&d experts. High-tech synthesis and high-difficulty peptide products: the company's young and dynamic research and development team has nearly 60 chemical synthesis personnel who have graduated from the specialty of chemical medicine and engaged in the research and development of biochemical medicine for several years. 80% of them have graduate and undergraduate degrees or above, and the average age is 33 years old. Professional and efficient research and development spirit is the guarantee of chengdu kaijie quality products and technical consultation. Technical services include:? Simple and complex; Linear, circularized; Long sequence polypeptides, up to 140 amino acids; Small to large quantities; Of different purity range (desalted, 75% >, 85% >, 90% >, 95% >, 98% >); Various modifications (access to biotin, phosphorylation, stain markers, etc.); Medicinal; Purification of different specifications; Protein binding; Excellent quality, fully in line with product requirements: chengdu kaijie strict production management and quality audit mechanism, is to provide quality peptide products guarantee. We provide quality products with the following test report: HPLC analysis chart; Mass spectrogram; Synthesis report; Nuclear magnetic; Infrared; Uv; Elemental analysis; Water content determination; Amino acid analysis; High efficiency, the shortest delivery cycle: chengdu capgemini biological medicine science and technology development co., LTD., built hundreds of level production workshop, and equipped with the most number of U.S. imports in domestic peptide synthesis equipment (CSBio automatic peptide synthesizer 20, contains the synthesis equipment 14 kg, multi-channel research and development equipment 2 sets,) favourable guarantee the mass products demand of customers. At the same time, the professional and efficient operation system -- r & d and production workshop is divided into three classes, working 24 hours non-stop, striving to deliver high-quality polypeptide products to customers within the shortest time. The domestic and international gold medal express customer, chengdu capgemini guarantees to deliver the product to your hand within the designated delivery cycle. Excellent service, all-around technical consultation: the 24-hour service hotline 400-628-7028 sales engineer and the polypeptide synthesis laboratory composed of the service team to answer your questions in a timely manner as well as the polypeptide data consultation service. Industrialized, the price has the most competitive power: take the lead to achieve industrialized API products, while ensuring high quality, the synthesis consumption will be reduced to the minimum, thus highlighting the price advantage. Its production of medical-grade polypeptide solid phase synthesis fully meets the requirements of USP, EP or CP, with single batch yield up to Kg level. Strong brand, take the lead in launching the concept of big customer to occupy the international market: since 2006, chengdu capgemini introduced the strengthened SAP management system, and carried out strict technical confidentiality and service follow-up system for all customers. The sales and marketing team of the company divides the real names of different customers into individuals to ensure the advantages and efficiency of the service. The company is the fastest growing customer volume in a short period of time, and its contracted customized synthetic customers as well as major customers of product supply, including internationally renowned pharmaceutical enterprises. Growing fast and reliable: the company's FDA plant is already under construction and is expected to be submitted for review in early 2011. Chengdu capgemini plans to apply for more than 20 varieties of GMP, its ability and strength in the international API arena leading!